REVISITING INHALED NITRIC OXIDE UTILIZATION IN CONGENITAL DIAPHRAGMATIC HERNIA: A NATIONAL COHORT STUDY OF MAJOR CHILDREN’S HOSPITALS IN THE UNITED STATES
Author / Expert
Anne M. Sescleifer, Charbel Chidiac, Zane J. Hellmann, Katherine M. McDermott, Alejandro V. Garcia, Daniel S. Rhee, Mark B. Slidell, Daniel G. Solomon, Shaun M. Kunisaki
Topic overview
For over a decade, there has been evidence suggesting a lack of efficacy of inhaled nitric oxide (iNO) in the treatment of pulmonary hypertension associated with congenital diaphragmatic hernia (CDH). Our study aimed to evaluate hospital-level data on contemporary iNO use in CDH infants.
Comments